Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
11
self-reported 11–50 band
Founded
2005
21 years
Legal entities
1
ABR
Office countries
1
1 address
Funding rounds
6
Series unknown · Sep 2020 · US$ 65.6K
Company type
Privately Held
self-reported
Legal entity
1 brand → 1 confirmed entity
IMPLICIT BIOSCIENCE LIMITED
ABN96108803489
Legal entities
Show as table · Implicit Bioscience: 1 registry entity
| IMPLICIT BIOSCIENCE LIMITED | ABN 96108803489 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
Implicit Bioscience is an unlisted public company based in Brisbane and Seattle. It was founded in 2005 by a number of biopharma veterans including Prof. Peter Andrews AO and Prof. Ian Frazer AC FRS; the company’s mission is to apply groundbreaking immunotherapy to treat serious and life-threatening diseases with few or no effective treatments.
Implicit Bioscience holds worldwide rights to IC14 and is developing it in the new field of immunoneurology for a range of neurodegenerative and neurotraumatic disease indications. IC14 is a biologic monoclonal antibody drug that inactivates CD14 on immune cells and in circulation. CD14 is a master regulator of the immune response that is also a key organiser of responses by the brain’s most common immune cell to infection and injury. Hyper-activated CD14 results in damaging inflammation that kills healthy brain and other cells in diseases such as MND/ALS.
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AU32 Logan Rd; Woolloongabba, Queensland 4102Primary
Grid intelligence Members
Funding
Last round · 28 September 2020US$ 65.6KSeries unknown
Rounds6
Round typeSeries unknown · venture round
Amount (USD)65,600
Stage ranknot recorded
Investors named0
Since last round5 yr 3 mo
Funding
Show as table · 6 funding rounds
| Rounds | 6 |
|---|---|
| Axis | 2005 to 2026 |
| Series unknown · 28 Sep 2020 | US$ 65.6K |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
FAQ
Which legal entity operates under Implicit Bioscience?
One Queensland entity on the ABR: IMPLICIT BIOSCIENCE LIMITED (ABN 96 108 803 489), high confidence.
How many people work at Implicit Bioscience?
11 counted staff profiles at January 2026, inside the self-reported 11–50 band.
Where does Implicit Bioscience have offices?
One address on record, Australia only. Primary: 32 Logan Rd, Woolloongabba, Queensland 4102.
Has Implicit Bioscience raised funding?
Six rounds. Latest 28 September 2020: Series unknown, US$65,600.
What does Implicit Bioscience list as its specialties?
One tag on the brand's own list, among them biotechnology.
Which companies are listed alongside Implicit Bioscience?
3 profiles list Implicit Bioscience as a peer — 49th percentile in Biotechnology Research. It lists ten peers of its own. Beta Cell Technologies and Curiosity Crisis Podcast list it back.